{
    "clinical_study": {
        "@rank": "147998", 
        "arm_group": {
            "arm_group_label": "repetitive TMS", 
            "arm_group_type": "Experimental", 
            "description": "repetitive TMS over dorsolateral prefrontal cortex, posterior superior temporal sulcus and inion as control"
        }, 
        "brief_summary": {
            "textblock": "rTMS over dorsolateral prefrontal cortex is effective in reducing repetitive behaviors in\n      adults with autistic spectrum disorder rTMS over posterior superior temporal sulcus is\n      effective in improving social ability in adults with autistic spectrum disorder"
        }, 
        "brief_title": "rTMS for Adults With Autistic Spectrum Disorder", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Autism", 
        "condition_browse": {
            "mesh_term": [
                "Autistic Disorder", 
                "Child Development Disorders, Pervasive"
            ]
        }, 
        "detailed_description": {
            "textblock": "First, we will apply one session intermittent theta burst stimulation over dorsolateral\n      prefrontal cortex, posterior superior temporal sulcus and inion as control with one week\n      interval in adults with autism spectrum disorder. Second, we will apply 5 sessions\n      intermittent theta burst stimulation within one week over dorsolateral prefrontal cortex or\n      posterior temporal sulcus depending on the results of our first phases."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  adults with autistic spectrum disorder\n\n        Exclusion Criteria:\n\n          -  schizophrenia\n\n          -  bipolar affective disorder\n\n          -  major depressive disorder\n\n          -  any systemic disease especially epilepsy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "40 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 2, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01918787", 
            "org_study_id": "100-2985C", 
            "secondary_id": "NSC 100-2314-B-182A-075"
        }, 
        "intervention": {
            "arm_group_label": "repetitive TMS", 
            "description": "rTMS (intermittent theta burst stimulation 1200)over posterior superior temporal sulcus,dorsolateral prefrontal cortex and inion as Sham control", 
            "intervention_name": "repetitive TMS", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "August 7, 2013", 
        "location": {
            "contact": {
                "email": "alanni0918@yahoo.com.tw", 
                "last_name": "Hsing Chang Ni", 
                "phone": "886-3-3281200", 
                "phone_ext": "2479"
            }, 
            "facility": {
                "address": {
                    "city": "Taoyuan", 
                    "country": "Taiwan"
                }, 
                "name": "Chang Gung Memorial Hospital"
            }, 
            "investigator": {
                "last_name": "Hsing Chang Ni, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Taiwan"
        }, 
        "number_of_arms": "1", 
        "official_title": "Examine the Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) Over the Symptoms of Autism Spectrum Disorder", 
        "other_outcome": {
            "description": "Autism Spectrum Quotient will be evaluated before and after rTMS. The time point of evaluation is before rTMS, one hour after rTMS, 3 days after rTMS and one week after rTMS.", 
            "measure": "Autism Spectrum Quotient", 
            "safety_issue": "No", 
            "time_frame": "Autism Spectrum Quotient will be evaluated before and after rTMS within one week"
        }, 
        "overall_contact": {
            "email": "alanni0918@yahoo.com.tw", 
            "last_name": "Hsing Chang Ni, MD", 
            "phone": "886-3-3281200", 
            "phone_ext": "2479"
        }, 
        "overall_official": {
            "affiliation": "Chang Gung Memorial Hospital at Linkou, Taiwan", 
            "last_name": "Hsing-Chang Ni, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Taiwan: Department of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "continuous performance test will be arranged before and after rTMS within one hour", 
            "measure": "continuous performance test", 
            "safety_issue": "No", 
            "time_frame": "continuous performance test will be arranged before and after rTMS within one hour"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01918787"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Yale-Brown Obsessive Compulsive Scale will be evaluated before and after rTMS. The time point of evaluation is before rTMS, one hour after rTMS, 3 days after rTMS and one week after rTMS.", 
            "measure": "Yale-Brown Obsessive Compulsive Scale", 
            "safety_issue": "No", 
            "time_frame": "Yale-Brown Obsessive Compulsive Scale will be evaluated before and after rTMS within one week"
        }, 
        "source": "Chang Gung Memorial Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Chang Gung Memorial Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2012", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2012"
    }
}